Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence. [electronic resource]
Producer: 20100301Description: 389-403 p. digitalISSN:- 1421-9824
- Aged
- Alzheimer Disease -- drug therapy
- Cholinesterase Inhibitors -- administration & dosage
- Donepezil
- Evidence-Based Medicine
- Galantamine -- administration & dosage
- Humans
- Indans -- administration & dosage
- Phenylcarbamates -- administration & dosage
- Piperidines -- administration & dosage
- Randomized Controlled Trials as Topic
- Rivastigmine
No physical items for this record
Publication Type: Journal Article; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.